IDXX Q3 2025 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$48B

Q3 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.1B+13.3% YoY

Gross Profit

$683M61.8% margin

Operating Income

$355M32.1% margin

Net Income

$275M24.8% margin

EPS (Diluted)

$3.40

QoQ Revenue Growth

-0.4%

Cash Flow

Operating Cash Flow

$402M

Free Cash Flow

$371M

Stock-Based Comp.

-$44M

Balance Sheet

Total Assets

$3.4B

Total Liabilities

$1.8B

Stockholders' Equity

$1.6B

Cash & Equivalents

$208M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$976M	+13.3%
Gross Profit	$683M	$596M	+14.6%
Operating Income	$355M	$304M	+16.8%
Net Income	$275M	$233M	+17.9%

Revenue Segments

Product

$656M59%

Service

$449M41%

Geographic Segments

UNITED STATES

$705M64%

EMEA

$245M22%

Asia Pacific

$91M8%

CANADA

$41M4%

Latin America

$23M2%